Get the Stockscreener App
1.55
1.27%
-0.02
After Hours:
1.56
0.01
+0.65%
Lava Therapeutics Nv stock is traded at $1.55, with a volume of 33,372.
It is down -1.27% in the last 24 hours and up +5.44% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.57
Open:
$1.566
24h Volume:
33,372
Relative Volume:
0.39
Market Cap:
$40.77M
Revenue:
$9.06M
Net Income/Loss:
$-50.39M
P/E Ratio:
-0.8073
EPS:
-1.92
Net Cash Flow:
$5.89M
1W Performance:
+0.00%
1M Performance:
+5.44%
6M Performance:
+21.09%
1Y Performance:
-4.91%
1-Day Range:
$1.54
$1.566
1-Week Range:
$1.53
$1.5892
52-Week Range:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.55 | 41.04M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
LAVA Therapeutics N.V. stock trend outlook and recovery path2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Is LAVA Therapeutics N.V. stock entering bullish territory2025 Earnings Surprises & Verified Entry Point Signals - Newser
Published on: 2025-09-03 06:43:52 - Newser
LAVA Therapeutics N.V. stock trend forecast2025 Big Picture & High Conviction Buy Zone Picks - Newser
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week - inkl
Earnings visualization tools for LAVA Therapeutics N.V.Weekly Stock Report & Low Volatility Stock Recommendations - Newser
Chart based analysis of LAVA Therapeutics N.V. trendsJuly 2025 Final Week & High Yield Stock Recommendations - Newser
What recovery options are there for LAVA Therapeutics N.V.Earnings Recap Report & Verified Chart Pattern Trade Signals - Newser
How cyclical is LAVA Therapeutics N.V.’s revenue stream2025 Bull vs Bear & Proven Capital Preservation Methods - khodrobank.com
What is LAVA Therapeutics N.V.’s book value per shareJuly 2025 Earnings & Weekly High Potential Stock Alerts - khodrobank.com
Will LAVA Therapeutics N.V. bounce back from current supportWeekly Gains Report & Smart Money Movement Tracker - Newser
What’s the fair value of LAVA Therapeutics N.V. stockMarket Trend Review & Real-Time Volume Analysis - khodrobank.com
What moving averages say about LAVA Therapeutics N.V.July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Combining price and volume data for LAVA Therapeutics N.V.Portfolio Return Report & Stock Portfolio Risk Management - Newser
Strategies to average down on LAVA Therapeutics N.V.Earnings Recap Summary & High Return Stock Watch Alerts - Newser
Can momentum traders help lift LAVA Therapeutics N.V.2025 Price Targets & AI Forecast Swing Trade Picks - Newser
Is LAVA Therapeutics N.V. a stock for growth or value investorsJuly 2025 Spike Watch & Long-Term Growth Plans - khodrobank.com
What chart patterns are forming on LAVA Therapeutics N.V.2025 Key Lessons & Real-Time Stock Price Movement Reports - khodrobank.com
Published on: 2025-09-02 00:19:42 - khodrobank.com
Published on: 2025-09-01 09:44:37 - Newser
Applying chart zones and confluence areas to LAVA Therapeutics N.V.Dividend Hike & Smart Allocation Stock Reports - Newser
Trendline Breach Raises Concern for LAVA Therapeutics N.V. Investors2025 Breakouts & Breakdowns & AI Enhanced Execution Alerts - beatles.ru
What earnings revisions data tells us about LAVA Therapeutics N.V.2025 Year in Review & Stock Portfolio Risk Control - Newser
Is now a turning point for LAVA Therapeutics N.V.Layoff News & Weekly Momentum Stock Picks - Newser
When is the best time to exit LAVA Therapeutics N.V.Market Risk Summary & Community Consensus Picks - Newser
Building trade automation scripts for LAVA Therapeutics N.V.July 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Signal strength of LAVA Therapeutics N.V. stock in tech scanners2025 Earnings Impact & Capital Protection Trading Alerts - Newser
Using Ichimoku Cloud for LAVA Therapeutics N.V. technicalsDividend Hike & Intraday High Probability Alerts - Newser
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):